Cytheris
Germany
deadacquired
acquired
Stage
1
Investors
About
Cytheris was a biopharmaceutical company that developed immunotherapies. It focused on using recombinant human Interleukin-7 (r-hIL-7) to treat immune deficiencies.
Explore Cytheris's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.